Real-world evidence (RWE) expert with 12+ years in health economics and outcomes research. Leads RWE strategy and analytics, specializing in claims and EMR data, chart reviews, and secondary data landscape assessment. Expertise spanning oncology, infectious diseases, nephrology, hepatology, and rare diseases, with additional experience in economic modeling and market access strategy.